Retrace AV Header Background Image


Retrace AV Product Image


Infectious microbes are a constant threat in our natural environment. The risk these pose increases in built environments due to the decrease in ventilation and the increased interactions between people. A surface coated with paint or varnish containing Retrace-AV actively destroys a wide range of gram-positive bacteria, gram-negative bacteria, enveloped viruses, non-enveloped viruses and fungi to significantly reduce the risk to public health.

Upon infection from any pathogen, the immune system is put under stress whilst it acts to kill the infectious organism. It is during this time, when our bodies are stressed and our immune system weakened by the primary infection, that we are vulnerable to secondary infections from other pathogens. If an individual contracts an initial bacterial infection causing pneumonia and then is infected with Coronavirus, the demand on the respiratory system would be severe and potentially life threatening.

The anti-pathogenic activity of Retrace-AV reduces opportunistic primary and secondary infections in the built environment, and its effectiveness will remain active for many years (tested and accredited for 10 years) before requiring recoating. The efficacy should be verified annually by a registered service provider: contact for details.


All testing has been provided by ISO 17025:2017 accredited commercial, university and medical laboratories to the leading international standards, including:

ISO 21702:2019 ‘Measurement of antiviral activity on plastics and other non-porous surfaces.’ LEARN MORE >

ISO 22196:2011 ‘Measurement of antibacterial activity on plastics and other non-porous surfaces.’ LEARN MORE >

ISO 11607:2020 ‘Accelerated Aging of Sterile Barrier Systems for Medical Devices.’ LEARN MORE >

The testing confirms Retrace-AV meets virucidal and bactericidal efficacy standards.


Coverage in the media is making the case for additional protection measures against the threat of COVID-19.

The Swiss Cheese Model, first created by Ian M Mackay, a virologist at the University of Queensland, Australia, highlights the need for multiple layers of defence, and Retrace-AV offers one such powerful layer of defence. READ MORE >

This compelling article in The Atlantic reiterates the case, as this quote highlights: “Here, then, is the current pandemic dilemma: Vaccines remain the best way for individuals to protect themselves, but societies cannot treat vaccines as their only defense… ‘we need to take advantage of every single tool we have at our disposal.” READ MORE >


Our educational cartoon promotes understanding of surface hygiene and the role Retrace-AV can play in eliminating infectious microbes. We encourage you to share it across your social channels to spread the word.

Cartoon Image 1 Cartoon Image 2 Cartoon Image 3



Retrace AV Limited PO Box 100, Moreton-in-Marsh, GL56 0AN.

Sale and distribution in certain jurisdictions is restricted by regulation - click here for more information.